tirzepatide and libido sexual function study 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — Tirzepatide Program Archives - Duluth

doi:10.1371/journal.pone.0273004

For patients starting fresh, or switching from semaglutide for efficacy reasons, tirzepatide remains the more proven option at comparable weight loss levels without the dysesthesia risk

ParksMorgan Stanley Wealth ManagementMobileAlabama$1M$1B$500K-10M$1-10MMary Anne PhillipsMerrill Private Wealth ManagementBirminghamAlabama$2.5M$674M$5-50M$3-30MNancy LiphamWells Fargo AdvisorsAnnistonAlabama$250K$408M$1-5M$750K-5MGlenda GoughMorgan Stanley Wealth ManagementHuntsvilleAlabama$250K$641M$2-10M$500K-4MNicole BarbeeMerrill Wealth ManagementBirminghamAlabama$1M$590M$1-10M$1-10MPennie KeeneMorgan Stanley Wealth ManagementHuntsvilleAlabama$500K$1.6B$3-50M$3-35MJenny HiteMadison Street Wealth Advisors | Raymond JamesHuntsvilleAlabama$1M$3B$1-100M$1-25MKitty DavenportEdward JonesHuntsvilleAlabama$0$326M$500K-5M$300K-2.5MAlison CreekbaumMerrill Wealth ManagementDothanAlabama$750K$320M$3-5M$1.5-5MLaurie RussellMerrill Wealth ManagementMontgomeryAlabama$500K$588M$5-500M$2.5-15MTracy HorneMerrill Wealth ManagementMontgomeryAlabama$250K$175M$1-5M$500K-3MCindy ClarkMerrill Wealth ManagementMontgomeryAlabama$250K$370M$1-2.5M$500K-1.2MJennifer RyderAmeriprise Financial ServicesMobileAlabama$250K$526M$300K-1M$200-700KJenny SneedSavant Wealth ManagementBirminghamAlabama$500K$2.1B$1-5M$1-3MBrenda ArmstrongEdward JonesHuntsvilleAlabama$0$259M$661K-10M$600K-3MRebecca BakerMarble WealthMontgomeryAlabama$500K$877M$5-20M$2-15MValerie R

Its advised to wait at least 30 minutes before eating or drinking anything other than water after taking the tablet